Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414395 | SCV000490978 | pathogenic | not provided | 2016-11-14 | criteria provided, single submitter | clinical testing | The R148X nonsense variant has been reported previously in association with 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL) (Wortmann et al. (2012). The R148X variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. In summary, we interpret R148X to be pathogenic. |
Baylor Genetics | RCV000029218 | SCV000992824 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2017-12-31 | criteria provided, single submitter | clinical testing | |
Center for Molecular Medicine, |
RCV000029218 | SCV001190548 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2019-05-10 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000414395 | SCV001447083 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000029218 | SCV002554869 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000029218 | SCV004801248 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2024-03-14 | criteria provided, single submitter | research | |
OMIM | RCV000029218 | SCV000051864 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2012-06-10 | no assertion criteria provided | literature only | |
Biochemical Molecular Genetic Laboratory, |
RCV000029218 | SCV001133068 | likely pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2019-09-26 | no assertion criteria provided | clinical testing | |
Pathology and Clinical Laboratory Medicine, |
RCV000029218 | SCV001438878 | likely pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | no assertion criteria provided | clinical testing | ||
Clinical Laboratory Sciences Program |
RCV000029218 | SCV003927950 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2023-04-01 | no assertion criteria provided | clinical testing |